Matches in Wikidata for { <http://www.wikidata.org/entity/Q62062051> ?p ?o ?g. }
Showing items 1 to 63 of
63
with 100 items per page.
- Q62062051 description "assaig clínic" @default.
- Q62062051 description "clinical trial" @default.
- Q62062051 description "clinical trial" @default.
- Q62062051 description "clinical trial" @default.
- Q62062051 description "clinical trial" @default.
- Q62062051 description "ensaio clínico" @default.
- Q62062051 description "ensayo clínico" @default.
- Q62062051 description "ensayu clínicu" @default.
- Q62062051 description "essai clinique" @default.
- Q62062051 description "klinisch onderzoek" @default.
- Q62062051 description "клінічне випробування" @default.
- Q62062051 description "կլինիկական փորձարկում" @default.
- Q62062051 description "临床试验" @default.
- Q62062051 name "Phase 3 Study of OTO-104 in Subjects With Unilateral Meniere's Disease" @default.
- Q62062051 type Item @default.
- Q62062051 label "Phase 3 Study of OTO-104 in Subjects With Unilateral Meniere's Disease" @default.
- Q62062051 prefLabel "Phase 3 Study of OTO-104 in Subjects With Unilateral Meniere's Disease" @default.
- Q62062051 P1132 Q62062051-5FA02319-E2F2-4A4F-8123-C9A5A24800FF @default.
- Q62062051 P1476 Q62062051-1F4DC43B-0CAB-401D-AC58-7DF2C62B35EC @default.
- Q62062051 P17 Q62062051-1BF0F43A-3F9C-45FC-9CF5-2921B6437DD1 @default.
- Q62062051 P17 Q62062051-ABE92E4A-7A82-48A3-B4C2-ACAAAEE53B4F @default.
- Q62062051 P17 Q62062051-CE87F126-0148-49B3-82DD-92849A0CA506 @default.
- Q62062051 P2899 Q62062051-ADB494DD-1C7D-4E21-B071-7E4FDC993606 @default.
- Q62062051 P3098 Q62062051-415A524F-8D81-49A2-88DE-673CE15503EF @default.
- Q62062051 P31 Q62062051-EDB8D3C9-F656-498E-9357-34A1CA1271BA @default.
- Q62062051 P4135 Q62062051-561AFF33-1812-4916-946C-1DD510A4A97B @default.
- Q62062051 P580 Q62062051-41798ED8-11EE-419C-BE56-A2FBC1B48D55 @default.
- Q62062051 P582 Q62062051-6E634EB4-542A-4E08-BD0C-A1C5C9AB45B5 @default.
- Q62062051 P6099 Q62062051-E3B7C2D1-3F73-4571-A515-162D4BE7F648 @default.
- Q62062051 P6153 Q62062051-24E5223F-3F71-4C9F-AEF6-F369DB1E2FDF @default.
- Q62062051 P6153 Q62062051-2F035DDE-8B2A-49D4-9ADF-A4E095055CB5 @default.
- Q62062051 P6153 Q62062051-34395D9C-30DF-4071-B203-42BD29989BD5 @default.
- Q62062051 P6153 Q62062051-366DA243-22A0-434A-A0D1-446F00C54195 @default.
- Q62062051 P6153 Q62062051-3AAA4715-BF62-45DA-9BE4-A1BB39F5A3CF @default.
- Q62062051 P6153 Q62062051-8B04C8C0-7FBB-4BE4-AC92-F5621D59FB5F @default.
- Q62062051 P6153 Q62062051-90C3909B-3819-46C9-B67E-D46DA88A0717 @default.
- Q62062051 P6153 Q62062051-BA7B2AE7-3795-49C1-AB29-5B43E29866AD @default.
- Q62062051 P6153 Q62062051-FD1937A5-8841-45E9-8C4B-CD1B89DB2100 @default.
- Q62062051 P8005 Q62062051-354BD788-0758-4F1E-929E-8147C6E8373B @default.
- Q62062051 P8363 Q62062051-683C9829-E52D-4FDC-B9A0-C1479A20F7FB @default.
- Q62062051 P1132 "+160" @default.
- Q62062051 P1476 "A Prospective, Randomized, Double Blind, Placebo-controlled, Multicenter, Phase 3 Efficacy and Safety Study of OTO-104 Given as a Single Intratympanic Injection in Subjects With Unilateral Meniere's Disease" @default.
- Q62062051 P17 Q145 @default.
- Q62062051 P17 Q183 @default.
- Q62062051 P17 Q30 @default.
- Q62062051 P2899 "+18" @default.
- Q62062051 P3098 "NCT03664674" @default.
- Q62062051 P31 Q30612 @default.
- Q62062051 P4135 "+75" @default.
- Q62062051 P580 "2018-08-27T00:00:00Z" @default.
- Q62062051 P582 "2020-05-01T00:00:00Z" @default.
- Q62062051 P6099 Q42824827 @default.
- Q62062051 P6153 Q1035745 @default.
- Q62062051 P6153 Q1468161 @default.
- Q62062051 P6153 Q27892167 @default.
- Q62062051 P6153 Q35794 @default.
- Q62062051 P6153 Q5902982 @default.
- Q62062051 P6153 Q5903026 @default.
- Q62062051 P6153 Q734774 @default.
- Q62062051 P6153 Q7914455 @default.
- Q62062051 P6153 Q84238284 @default.
- Q62062051 P8005 Q76649708 @default.
- Q62062051 P8363 Q78089383 @default.